Phoenix Molecular Designs Announces Manufacturing Collaboration with WuXi STA to advance PMD-026 toward IND

CisionPR Newswire_2.png

VANCOUVER, British Columbia and SAN DIEGO, April 16, 2018 - Phoenix Molecular Designs have entered into a collaboration with STA Pharmaceutical Co., Ltd (STA), a WuXi AppTec group company, to manufacture the PMD-026 needed for IND-enabling toxicology studies and a Phase I study in women.

Read the full press release here